Back in June 2020, we caught up withAcepodiafounder & CEO Dr. Sonny Hsiao to learn about his company’s initiative to change this cost paradigm. Later that year, the young entrepreneur recruited cell therapy pioneer and veteran Mark Gilbert, M.D. to lead the company’s R&D effort. That m...
Adoptive T cell therapy has the potential to enhance antitumor immunity, augment vaccine efficacy, and limit graft-versus-host disease. This form of personalized medicine is now in various early- and late-stage clinical trials. These trials are currently testing strategies to infuse tumor-...
Adoptive T cell therapy for cancer in the clinic The transfusion of lymphocytes, referred to as adoptive T cell therapy, is being tested for the treatment of cancer and chronic infections. Adoptive T cell... CH June - 《Journal of Clinical Investigation》 被引量: 1194发表: 2007年 Agonist ...
Chimeric antigen receptor (CAR)-T cell therapy has emerged to revolutionize cancer treatment, which has achieved promising success, especially in treating hematological malignancies like B-cell acute lymphocytic leukemia (B-ALL), multiple myeloma (MM), and non-Hodgkin lymphoma (NHL). The US Food a...
Scientists at the National Eye Institute (NEI), part of the National Institutes of Health, report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE)—a layer of cells in the back of the eye—are essentia
The identification of suppressor T cells as important regulators of basic processes that are designed to maintain tolerance has opened an important area of potential clinical investigation in autoimmunity, graft-versus-host disease and transplantation. H
In recent years,the clinical test about the application of CIK cells toward solid tumor therapy have been continued carrying out at home and abroad,this therapy showes powerful advantage to be more better than other adoptive immunity treatment during the clinical treatment,therefore it is applied to...
an emphasis on biomanufacturing requirements becomes necessary. Robust infrastructure should address current limitations in cell harvesting, expansion, manipulation, purification, preservation and formulation, ultimately leading to successful therapy administration to patients at an acceptable cost. In this Review...
- 《Stem Cell Research & Therapy》 被引量: 25发表: 2014年 Translating stem cell research to the clinic: a primer on translational considerations for your first stem cell protocol Over the last two decades, a new therapeutic paradigm has emerged which has changed the way debilitating diseases ma...
这first stem cell clinicof its kind,where we offer hope for improvement to patients with alternative therapy. 干细胞诊所started it all back in2012where our goal is not only on how can stem cells be used as therapy or treatments but also educate people about this new field so they know wha...